Skip to main content

Animations

MJFF Publications

8351 - 8360 of 8808 Results
Title
Year
  • Year
  • 2022
  • 2016
  • 2017
  • 2018
  • 2025
  • 2021
  • 2015
  • 2025
  • 2010
  • 2020
  • Summary Details
    OPEN
    Title: DARQ: Deep learning of quality control for stereotaxic registration of human brain MRI to the T1w MNI-ICBM 152 template
    Journal Name: NeuroImage
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.neuroimage.2022.119266
    Citation Count: 15
  • Summary Details
    OPEN
    Title: Discovery of 3-aminopicolinamides as metabotropic glutamate receptor subtype 4 (mGlu4) positive allosteric modulator warheads engendering CNS exposure and in vivo efficacy
    Journal Name: Bioorganic & Medicinal Chemistry Letters
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.bmcl.2016.04.041
    Citation Count: 3
  • Summary Details
    RESTRICTED
    Title: Endocytic vesicle rupture is a conserved mechanism of cellular invasion by amyloid proteins
    Journal Name: Acta Neuropathologica
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/s00401-017-1722-x
    Citation Count: 248
  • Summary Details
    RESTRICTED
    Title: Small intestinal bacterial overgrowth in Parkinson's disease: Tribulations of a trial
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.04.003
    Citation Count: 35
  • Summary Details
    OPEN
    Title: Integrated multi-omics highlights alterations of gut microbiome functions in prodromal and idiopathic Parkinson’s disease
    Journal Name: Microbiome
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s40168-025-02227-2
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: MicroRNAs as Molecular Biomarkers for Parkinson's Disease Progression
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.28700
    Citation Count: 1
  • Summary Details
    RESTRICTED
    Title: A novel retinal biomarker for Parkinson's disease: Quantifying the foveal pit with optical coherence tomography
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.26411
    Citation Count: 23
  • Summary Details
    OPEN
    Title: Blocking the Dkk1-LRP6 interaction prevents acute amyloid-β-driven cognitive impairment
    Journal Name: Cellular Signalling
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.cellsig.2025.111716
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Mitochondrial therapies for Parkinson's disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.22781
    Citation Count: 58
  • Summary Details
    RESTRICTED
    Title: Reversible orolingual dyskinesia in a case of juvenile onset psychosis and cognitive decline: Expert commentary
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.12.015
    Citation Count: 1
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.